Tianjin, China – Haifu Technology showcased its latest innovations in AI-powered non-invasive medicine at the 2026 World Intelligence Expo, highlighting how artificial intelligence is accelerating the future of focused ultrasound therapy.

At the Chongqing Pavilion, Haifu presented its flagship HIFU (High-Intensity Focused Ultrasound) Tumor Therapeutic System alongside its consumer healthcare products, demonstrating China's leadership in original focused ultrasound technology.

Since developing China's first HIFU tumor therapeutic system with independent intellectual property rights in 1999, Haifu has become a global pioneer in focused ultrasound. Today, Haifu systems are installed in 37 countries and regions, bringing non-invasive treatment to patients around the world.

A key highlight was the Model JC300 Focused Ultrasound Therapeutic System, which integrates AI-assisted planning, intelligent data analysis, and synchronized ultrasound-MRI imaging to provide enhanced treatment precision and workflow efficiency. The system represents Haifu's vision of building a smarter, fully integrated non-invasive treatment platform.

During the exhibition, Xi Wang, Manager of Haifu Health Products Division, delivered a presentation on "AI + High-Intensity Focused Ultrasound: Intelligent Upgrades and Clinical Expansion of Non-Invasive Therapy." The presentation highlighted how AI-assisted treatment planning and real-time image guidance are improving precision, efficiency, and the future of intelligent HIFU therapy.

By combining artificial intelligence with original focused ultrasound technology, Haifu Technology continues to advance smarter, safer, and more accessible non-invasive healthcare for patients worldwide.